Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents.

Roberto Mina, Nisha S. Joseph, Francesca Gay, Efstathios Kastritis, Maria Teresa Petrucci, Jonathan L. Kaufman, Vittorio Montefusco, Maria Gavriatopoulou, Francesca Patriarca, Paola Omedé, Lawrence H. Boise, Maria Roussou, Nicola Giuliani, Stefania Oliva, Massimo Offidani, Angelo Belotti, David L. Jaye, Lorenzo De Paoli, Evangelos Terpos, Sagar LonialMario Boccadoro, Ajay K. Nooka, Meletios A. Dimopoulos

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)40
Number of pages1
JournalBlood Cancer J.
Issue number4
Publication statusPublished - Apr 1 2020


  • Adult
  • Female
  • Humans
  • Male
  • Middle Aged
  • Survival Rate
  • Aged
  • Prognosis
  • 80 and over
  • Transplantation
  • Autologous
  • *Translocation
  • Genetic
  • Chromosomes
  • Human
  • Pair 14/*genetics
  • Pair 16/*genetics
  • Hematopoietic Stem Cell Transplantation/*mortality
  • Multiple Myeloma/genetics/*mortality/pathology/therapy

Cite this